Patents by Inventor John Glawe

John Glawe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCR4 and ROBO1 expression as markers for autoimmune diabetes
    Patent number: 10697960
    Abstract: CXCR4 and ROBO-1 are biomarkers associated with type 1 diabetes. Expression of CXCR4 and ROBO-1 in peripheral CD3 T cells is substantially higher in patients with autoimmune diabetes (type 1 diabetes) than in non-diabetic patients. Therapies are disclosed for reducing the progression of type 1 diabetes, and to reduce the risk of developing type 1 diabetes in patients who are at risk of developing type 1 diabetes.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: June 30, 2020
    Assignee: BOARD OF SUPERVISORS OR LOUISANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
    Inventors: Christopher Kevil, Robert McVie, John Glawe
  • CXCR4 and ROBO1 expression as markers for autoimmune diabetes
    Patent number: 9234886
    Abstract: CXCR4 and ROBO-1 are biomarkers associated with type 1 diabetes. Expression of CXCR4 and ROBO-1 in peripheral CD3 T cells is substantially higher in patients with autoimmune diabetes (type 1 diabetes) than in non-diabetic patients. Therapies are disclosed for reducing the progression of type 1 diabetes, and to reduce the risk of developing type 1 diabetes in patients who are at risk of developing type 1 diabetes.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: January 12, 2016
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Christopher Kevil, Robert McVie, John Glawe
  • CXCR4 AND ROBO1 EXPRESSION AS MARKERS FOR AUTOIMMUNE DIABETES
    Publication number: 20140073565
    Abstract: CXCR4 and ROBO-1 are biomarkers associated with type 1 diabetes. Expression of CXCR4 and ROBO-1 in peripheral CD3 T cells is substantially higher in patients with autoimmune diabetes (type 1 diabetes) than in non-diabetic patients. Therapies are disclosed for reducing the progression of type 1 diabetes, and to reduce the risk of developing type 1 diabetes in patients who are at risk of developing type 1 diabetes.
    Type: Application
    Filed: September 12, 2013
    Publication date: March 13, 2014
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Christopher Kevil, Robert McVie, John Glawe
  • Machine for automatically removing the protective coverings from temporary raised pavement markers (TRPMs)
    Patent number: 6685389
    Abstract: Apparatus for removing protective coverings from temporary raised pavement markers (TRPM) fixedly secured upon roadway surfaces comprises a platform, and a plurality of toothed implements disposed beneath the platform for encountering and removing the protective coverings mounted upon the upstanding vertical reflective portions of the temporary raised pavement markers (TRPM). The toothed implements are mounted upon a chain which is driven by a motor mounted upon an upper surface portion of the platform, and a blower is also mounted upon the upper surface portion of the platform. An exhaust duct, fluidically connected to the intake side of the blower, passes through a suction port defined within the platform so as to be fluidically connected to the underside of the platform, and in this manner, the removed protective coverings of the temporary raised pavement markers (TRPM) may be removed from the roadway surface and conveyed to a suitable debris collection bag.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: February 3, 2004
    Assignee: Illinois Tool Works Inc.
    Inventors: Michael Christensen, John Glawe, Chad Orthaus, Jeffrey Arnold Wilkens